What is Talus Bioscience?
Talus Bioscience is a drug discovery company founded by a world-class team of scientific leaders specializing in proteomics, biochemistry, and machine learning. The company leverages its deep expertise in these critical scientific domains to advance novel therapeutic approaches. Its focus on integrating advanced computational methods with biological insights positions it at the forefront of modern pharmaceutical research and development.
How much funding has Talus Bioscience raised?
Talus Bioscience has raised a total of $20.9M across 2 funding rounds:
Unspecified
$9.8M
Angel/Seed
$11.2M
Unspecified (2022): $9.8M, investors not publicly disclosed
Angel/Seed (2024): $11.2M led by WRF Capital, The NFX, and Two Bear Capital
Key Investors in Talus Bioscience
WRF Capital
WRF Capital, the investment arm of the Washington Research Foundation, is a prominent early-stage investor focused on commercializing innovative ideas, particularly in life sciences and technology within Washington state. They provide crucial seed funding and strategic support to startups emerging from research institutions.
The NFX
NFX is a venture capital firm that invests in pre-seed and seed-stage startups, with a focus on transformative companies across sectors like gaming, AI, and fintech. They offer not only capital but also valuable resources and a strong founder community.
Two Bear Capital
Two Bear Capital is an investment firm dedicated to supporting founders who are tackling complex challenges in life sciences and technology. They operate from key innovation hubs and collaborate with entrepreneurs to build impactful companies.
What's next for Talus Bioscience?
The recent major strategic investment signals a pivotal moment for Talus Bioscience, likely enabling the company to accelerate its drug development pipeline, expand its research capabilities, and potentially forge new partnerships. This infusion of capital is expected to fuel further innovation and move its promising discoveries closer to clinical application, solidifying its position in the competitive biotech landscape.
See full Talus Bioscience company page
